Brent Gardner

Brent Gardner has had extensive work experience in the medical affairs field. Brent currently holds the position of Executive Director of Medical Affairs at AVEO Oncology since 2022. Prior to this, they worked at Epizyme as an Executive Medical Director and later as an Executive Director of Field Medical Affairs from 2020 to 2022. Brent also served as a Regional MSL Director at Epizyme for a brief period in 2020. Before joining Epizyme, they held the role of Senior Director of Medical Affairs at Partner Therapeutics from 2017 to 2020. Additionally, they worked as a Medical Director at Merrimack Pharmaceuticals from 2015 to 2017. Brent held the position of Director of Scientific and Medical Affairs at Biodesix, Inc. in 2014 and worked as a Medical Science Liaison at Bayer from April to November 2014. Prior to that, they served as a Medical Science Liaison at Algeta ASA from 2013 to 2014. Brent began their career as a Nuclear Pharmacist at IBA Molecular from May to December 2012, and before that, they held the role of Area Operations Director at Triad Isotopes from 2010 to 2012. Lastly, they worked as an Area Pharmacy Manager at Covidien from 2002 to 2010.

Brent Gardner holds a Doctor of Pharmacy (PharmD) degree from Purdue University. The duration of their education at Purdue University is not specified.